ArticlePloS one2025
Facilitators and barriers to contraceptive uptake and use: Perspectives of female students in South Africa and lessons for quality provision of HIV pre-exposure prophylaxis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge, attitudes, and behavioural intention towards HIV pre-exposure prophylaxis among health science students in South Africa: cross-sectional study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Young women in South Africa face a dual risk of unplanned pregnancies and HIV infections. The country's high contraceptive prevalence rate masks underlying challenges affecting the initiation and maintenance of contraceptive use. Options are freely available at public health clinics and most women in the country use long-acting injectable contraceptives. Young women's experiences of contraceptive services provide a unique opportunity to learn lessons for long-acting HIV Pre-exposure prophylaxis (PrEP). The paper aims to explore facilitators and barriers to using contraceptives among young female students to inform the delivery of long-acting PrEP. A qualitative study was conducted in one district in Gauteng province of South Africa. We purposively selected female students 18-24 years seeking sexual and reproductive health services (SRH) through fixed or mobile clinics in 2022 on two campuses. We conducted 22 in-depth interviews and five Focus Group Discussions (FGDs). Data were thematically analysed using NVivo 12 software. Individual-related barriers were mainly related to the side effects of contraceptives. At a family level, mothers sometimes played a supportive role which enabled continued contraceptive use, yet partners' concerns about side effects were sometimes a barrier. Health systems-related issues included negative health provider attitudes and unfavourable opening hours. Accessing contraceptives over holidays when students travelled was a challenge. Long-acting injectable PrEP may be compatible with injectable contraceptives and could provide an opportunity to align visits. Training service providers on the importance of detailed information on side effects will be crucial. Promoting PrEP among mothers and partners could increase support for continued PrEP use. These lessons can be applied to delivering new long-acting HIV PrEP products near the market.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.